Pancreatic Cancer Europe recently interviewed Christina Gerde, patient representative and member of the Pancreatic Cancer Diagnosis Working Group at PALEMA. In her powerful message, Christina reminds us. More needs to be done for pancreatic cancer for survival rates to go up. The time for that is now.
Välkommen att kontakta PALEMAs redaktion om du har förslag på artiklar eller synpunkter på artiklar vi skrivit.
Dela - Mejla - Skriv ut:
This year, PALEMA decided to attend the Almedal Week to assess whether it is a platform the association should continue to focus on in the future.
Results from a major international study are raising hopes for one of the biggest breakthroughs in pancreatic cancer in decades.
For many people with pancreatic cancer, surgery is not an option at the time of diagnosis. But that doesn’t mean treatment stops—it means the treatment strategy changes.
Christina Gerde speaks on behalf of those who cannot speak for themselves, those living with pancreatic cancer, and those who have lost loved ones to the disease. She was diagnosed three years ago and shares the reality of a disease where relapse is common and treatment options remain limited.
